topstockalerts
Jim Cramer offered mixed assessments of five stocks during CNBC’s “Mad Money” Lightning Round, highlighting opportunities in pharmaceuticals while warning about interest-rate risks and reassessing a potential takeover scenario.
Cramer expressed support for Jazz Pharmaceuticals, saying he was willing to invest despite the stock’s speculative nature. He noted that the company is profitable, suggesting its financial performance provides some support for the investment case even as uncertainty remains. Jazz shares were trading at $218.42, down 1.81% during Friday’s session.
Cramer also revisited EchoStar after a report suggested that SpaceX could make a takeover bid for the satellite communications company. Although he had previously been skeptical of EchoStar, he said the potential transaction was compelling enough that he could not ignore it. However, the report did not confirm that SpaceX had made a formal offer, leaving the possibility speculative.
$JAZZ $APLE $ECHO $SPCX
3
